login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
GAMIDA CELL LTD (GMDA) Stock News
NASDAQ:GMDA -
IL0011552663
-
Common Stock
0.0327
USD
-0.01 (-18.25%)
Last: 4/5/2024, 8:00:00 PM
0.032
USD
0 (-2.14%)
After Hours:
4/5/2024, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GMDA Latest News, Press Relases and Analysis
All
Press Releases
a year ago - By: HOOKIPA Pharma Inc.
- Mentions:
HOOK
ARVN
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
a year ago - By: InvestorPlace
- Mentions:
MDIA
FAAS
HUBC
GRIN
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
a year ago - By: Benzinga
- Mentions:
QH
EGOX
APLD
KTRA
...
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
a year ago - By: BusinessInsider
GMDA Stock Earnings: Gamida Cell Beats EPS, Beats Revenue for Q4 2023
a year ago - By: Benzinga
Why Gamida Cell Shares Are Falling Today
a year ago - By: Aquestive Therapeutics, Inc.
- Mentions:
AQST
EBS
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
a year ago - By: InvestorPlace
- Mentions:
AVTX
BCG
PIK
CZOO
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
a year ago - By: InvestorPlace
- Mentions:
DJT
RDDT
GME
Trump Media (DJT) Stock Jumps 18% in Second Trading Day
a year ago - By: InvestorPlace
GMDA Stock Earnings: Gamida Cell Beats EPS, Beats Revenue for Q4 2023
a year ago - By: InvestorPlace
- Mentions:
RDDT
JOAN
CLRB
Hedgeye Warns That Reddit (RDDT) Stock Will Fall 50%
a year ago - By: InvestorPlace
- Mentions:
JOAN
CLRB
LE
Why Is Gamida Cell (GMDA) Stock Down 82% Today?
a year ago - By: Gamida Cell, Ltd
Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
a year ago - By: Gamida Cell, Ltd
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
a year ago - By: Gamida Cell, Ltd
Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results
2 years ago - By: Gamida Cell, Ltd
Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
2 years ago - By: Seeking Alpha
Gamida Cell stock jumps as company explores strategic alternatives (NASDAQ:GMDA)
2 years ago - By: Gamida Cell, Ltd
Gamida Cell Actively Pursuing Strategic Alternatives
2 years ago - By: Gamida Cell, Ltd
Gamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023
2 years ago - By: Gamida Cell, Ltd
Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference
2 years ago - By: Seeking Alpha
Gamida Cell files for $150M mixed shelf (NASDAQ:GMDA)
2 years ago - By: Gamida Cell, Ltd
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
2 years ago - By: Gamida Cell, Ltd
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
2 years ago - By: Gamida Cell Ltd.
Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
2 years ago - By: Gamida Cell Ltd.
Gamida Cell Issues Update on Israel Operations
2 years ago - By: Gamida Cell Ltd.
Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa
Please enable JavaScript to continue using this application.